FDA warning Tagged Articles
FDA wants more safety data before it will approve new type 2 diabetes drugs
Takeda Pharmaceutical Co. will have to produce more evidence on the safety of two new type 2 diabetes medications, delaying even more what has been a long road to Food and Drug Administration (FDA) approval. Takeda is seeking United States
Woman sues bladder sling maker for failing to warn about possible complications
“I never had this before, nothing so bad that you could just sit down and cry. You just don’t know what’s going on with your body.” Canadian resident Diane McLaughlin recalls the severe pain she experienced shortly after surgery in 2006
Blood thinners more dangerous for people with clotting disorders
Bleeding disorders are more common than most people realize, and often go undiagnosed. The most common type of bleeding disorder is von Willebrand disease (VWD), a condition in which the blood does not clot properly. When injury occurs in patients
Cardiology group compares safety of blood thinners
A group of researchers from the European Society of Cardiology have found what they say is the best-documented alternative to the blood thinners warfarin and aspirin for the prevention of stroke in patients with a type of irregular heartbeat known
New therapy could one day provide better treatment options for diabetics
A novel new therapy to treat type 2 diabetes that lowers blood sugar, decreases insulin resistance, lowers cholesterol and helps keep fatty deposits from settling in the liver is in the works at Columbia University Medical Center, and researchers hope
FDA warns of eye infections with drugs used in eye surgeries
More reports of eye infections caused by fungal endophthalmitis in patients who were treated with Brilliant Blue G (BBG) during eye surgery have prompted the Food and Drug Administration (FDA) to issue a second warning in a month’s time about
Hypertension drug combination contraindicated in patients with diabetes, renal impairment
The Food and Drug Administration (FDA) issued a warning for patients with type 2 diabetes or kidney (renal) impairment about possible risks when these patients use blood pressure medications containing aliskiren with other hypertension drugs called angiotensin converting enzyme inhibitors
Accidental exposure to fentanyl skin patch can be deadly to kids
The Food and Drug Administration (FDA) is warning patients, caregivers and health care providers that accidental exposure to the skin patch containing the powerful painkiller fentanyl can be deadly, especially to young children, and that extra caution should be exercised
